In yet another public/private partnership, this time between the CDC and Ginkgo Bioworks and XWELL Implement, the public is going to be shaken down with nasal testing, aircraft testing, and wastewater sampling at airports for a “Traveler-based Genomic Surveillance Program” (TGS) to test for more than 30 pathogens in addition to COVID at four of the program’s seven major international airports (NY – JFK, San Francisco, Boston, and Washington DC – Dulles).
The program has “enrolled” more than 360,000 passengers since implementation in late 2021. So far they state it is “voluntary and anonymous,” and covers flights from more than 135 countries (from all WHO regions), but taking off your shoes at airports also used to be temporary solution to 911, but has now been a regular fixture in airports for 22 years.
“Nothing is so permanent as a temporary government program.” ~ Milton Friedman
https://www.theepochtimes.com/epochtv/cdc-makes-big-airport-announcement-facts-matter Video Here (Approx. 6 Min)
CDC Makes Big Airport Announcement | Facts Matter
“The expansion of the Traveler-based Genomic Surveillance program to flu, RSV, and other pathogens is essential as we head into fall respiratory season. The TGS program, which began during the COVID-19 pandemic, acted as an early warning system to detect new and rare variants of the SARS-CoV-2 virus and will do the same for other respiratory viruses going forward,” the CDC said.